Syndromic Surveillance (SS)
The PHIN Messaging Guide for Syndromic Surveillance: Emergency Department, Urgent Care, Inpatient and Ambulatory Care Settings, Release 2.0 (April, 2015) is now available on the National Syndromic Surveillance Program (NSSP) Website (https://www.cdc.gov/nssp/news.html).
Public health syndromic surveillance using inpatient and ambulatory clinical care electronic health record (EHR) data is a relatively new practice. As eligible health professionals and hospitals adopt, implement, and upgrade their EHR systems through the CMS EHR Incentive programs (Meaningful Use programs), there is an opportunity for public health agencies (PHAs) to routinely receive health data from settings other than emergency departments and urgent care centers. Given the number of factors and complex relationships that affect EHR data quality, a collaborative approach that includes public health, healthcare, and EHR technology developers is the best way to determine how EHR data can be meaningfully used for surveillance.
In November 2012 the International Society for Disease Surveillance (ISDS) released Electronic Syndromic Surveillance Using Hospital Inpatient and Ambulatory Clinical Care EHR Data: Recommendations from the ISDS Meaningful Use Workgroup (Recommendations). These Recommendations are the product of an ISDS-convened Meaningful Use (MU) Workgroup that used their various stakeholder perspectives and expertise in public health practice and medical informatics to guide the document’s development. With the facilitation of ISDS staff, the Centers for Disease Control and Prevention (CDC), and HLN Consulting, the MU Workgroup used an iterative development process, soliciting stakeholder feedback at project initiation and twice while recommendations were developed. The Workgroup used both stakeholder input and their own expertise to draft Recommendations that balance current feasibility and resource concerns with community enthusiasm for surveillance innovation with these clinical data.
The finalized Recommendations provide clarity for Stage 2 Meaningful Use, when on-going syndromic surveillance reporting will be required for eligible hospitals. They also provide a basis for planning and establishing data use relationships between PHAs and eligible professionals or hospitals while building upon prior ISDS work by incorporating both lessons learned and broader stakeholder participation. Additionally, the Recommendations suggest Stage 3 of Meaningful Use rules for the syndromic surveillance objective and future EHR certification criteria.
To view the final Recommendations and learn more about the project, please visit the ISDS MU Inpatient and Ambulatory pageexternal icon.
Message mapping guides for syndromic surveillance are available at: https://www.cdc.gov/nssp/technical-pubs-and-standards.html#MMGs.
One tool that CDC offers for electronic message validation is the Message Evaluation and Testing Service (METS). This tool ensures that messages are adhering to HL7 standards defined in messaging guides. More details about METS may be found here.
NIST Test Procedure for syndromic surveillance
- Test Procedure for §170.302.l Public Health Surveillance APPROVED Version 1.2; December 28, 2010external icon Applied until 12/31/2012
- Test Procedure for §170.314(f)(3) Transmission to public health agencies – syndromic surveillance Approved Version 1.2 December 14, 2012pdf iconexternal icon
- Meaningful Use Certification Test Toolexternal icon